GlassScriptPhysician profile
Lauren S Dhar
NPI 1376956151
$3,466.91
in general payments reported to CMS, 2019-2025
15 companies · $640 in 2025
The $640 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $221 · 2020: $39.95 · 2021: $59.32 · 2022: $519 · 2023: $859 · 2024: $1,129 · 2025: $640.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,628.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,628.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,841.00 | 2022-2025 | Xen Glaucoma Treatment System, Lumigan, Alphagan P |
| Glaukos Corporation | $422.52 | 2019-2024 | Idose, Radius |
| Alcon Vision LLC | $234.32 | 2019-2025 | Rocklatan |
| Bausch & Lomb Americas INC. | $215.98 | 2022-2023 | Ic-8 Apthera Iol, Envista Mx60 Iol |
| New World Medical,INC. | $186.70 | 2023-2025 | Clearpath, Ahmed Glaucoma Valve, Kahook Dual Blade |
| Allergan, INC. | $182.76 | 2019-2021 | |
| Thea Pharma INC. | $109.83 | 2022-2025 | Iyuzeh |
| Oyster Point Pharma, INC. | $78.05 | 2022-2024 | Ryzumvi, Tyrvaya |
| Sight Sciences, INC. | $65.90 | 2023-2025 | Omni Surgical System |
| Novartis Pharmaceuticals Corporation | $24.21 | 2023 | |
| Nova Eye, INC. | $24.02 | 2023 | |
| Biotissue Holdings INC. | $22.18 | 2022 | |
| Carl Zeiss Meditec USA, INC. | $20.74 | 2022 | |
| Halozyme INC | $20.35 | 2022 | |
| Rxsight INC | $18.35 | 2025 | Rxsight Contact Lens, Rxsight Injector Cartridge, Light Adjustable Lens (Lal) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Dhar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.